1

Screenshot-at-May-17-20-31-13

05.17.2020

Related Articles

Patient-Centered Research: Challenges in Gathering and Analyzing Patient Experience Data in a Real-World Setting

Introduction The FDA and EMA are committed to gathering more patient experience data for drug approvals and capturing real-world evidence for effectiveness evaluation. This post reviews ISPOR’s second plenary panel discussion in Vienna 2022 on patient-centered research and its challenges in gathering and analyzing patient experience data in a real-world setting, particularly within the EU. […]

Read all
The Pharma Market Access Landscape in the Middle East and North Africa: The Next Ten Years

Introduction The market access landscape in the Middle East and North Africa (MENA) is dynamic and rapidly changing. MENA is diverse, comprising many dissimilar countries, with different cultures, including languages, used in commerce. The concerns about the long-term sustainability of oil revenues are driving to shape healthcare markets. There are different approaches to regulating healthcare […]

Read all
Together for Access to Innovative Treatments.

Panel Theme “Together for Access to Innovative Treatments.” 20 June 2022. Organizer Todos Juntos Contra on Cancer (TJCC). TJCC is composed of more than 200 institutions from different sectors engaged in improving cancer care in Brazil and aims to improve policies for Oncology. https://tjcc.com.br/ Panelists Prof. João L. Carapinha Dr. Antonio Carlos Buzaid Dr. José […]

Read all
Read all articles